STAR 3 Study

Summary

The use of sensor-augmented pump therapy resulted in significant decreases in HbA1C compared with multiple daily injection therapy across age groups, according to findings from the Sensor-Augmented Pump Therapy for A1C Reduction 3 [STAR 3; NCT00406133].

  • Hyperglycemia/Hypoglycemia
  • Diabetes Mellitus
  • Diabetes & Endocrinology Clinical Trials
View Full Text